Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

PHD3 Recombinant Antibody

Product Specifications

Background

Prolyl hydroxylase that mediates hydroxylation of proline residues in target proteins, such as PKM, TELO2, ATF4 and HIF1A.Target proteins are preferentially recognized via a LXXLAP motif. Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins.

Synonyms

Egl nine homolog 3; EGLN3; Factor responsive smooth muscle protein; HIF Prolyl Hydroxylase 3; HIFP4H3; HIFPH3; P4H3; PHD3; SM20.

Gene ID

112399

Swiss Prot

Q9H6Z9

Cellular Locus

Nucleus

Host

Rabbit

Cross Reactivity

Human, Mouse, Rat

Target

PHD3

Clonality

Recombinant

Isotype

IgG

Conjugation

Unconjugated

Source

KLH conjugated synthetic peptide derived from human PHD3

Applications

WB, IP, ICC/IF

Purification

Purified by Protein A.

Concentration

Lot dependent

Dilution

WB (1:300-5000), IP (1-2ug), ICC/IF (1:50-100)

Buffer

0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol

Modification

Unmodified

Storage Conditions

Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.

Product Datasheet

https://www.biossantibodies.com/datasheets/bsm-62480R

Gene ID URL

112399

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

HBSS
BS16000B 1 L

HBSS

Ask
View Details
V6 Anti-Human C5 (Ravulizumab)
B23152901-01 1 mg

V6 Anti-Human C5 (Ravulizumab)

Ask
View Details
V6 Anti-Human C5 (Ravulizumab)
B23152901-02 5 mg

V6 Anti-Human C5 (Ravulizumab)

Ask
View Details
V6 Anti-Human C5 (Ravulizumab)
B23152901-03 25 mg

V6 Anti-Human C5 (Ravulizumab)

Ask
View Details
V6 Anti-Human C5 (Ravulizumab)
B23152901-04 50 mg

V6 Anti-Human C5 (Ravulizumab)

Ask
View Details
V6 Anti-Human C5 (Ravulizumab)
B23152901-05 100 mg

V6 Anti-Human C5 (Ravulizumab)

Ask
View Details